Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $184.00 to $157.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price would [...]
Wells Fargo & Company Has Lowered Expectations for Becton, Dickinson and Company (NYSE:BDX) Stock Price